Exercise ECG to tell hypertensive heart disease from obstructive CAD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this prospective observational study, adults suspected of having coronary artery disease will undergo exercise ECG, echocardiography, stress CMR, and CCTA. Participants will be grouped by the presence or absence of left ventricular hypertrophy and obstructive CAD, with stress CMR serving as the reference for inducible ischemia. The researchers will compare ECG patterns across groups and use multivariable analysis to identify ECG predictors of obstructive CAD and ischemia. The goal is to determine how well exercise ECG can differentiate hypertensive heart disease from CAD-related abnormalities. No interventions are being tested, just diagnostic imaging correlations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with CAD and LVH

Exclusion Criteria:

* Patients with RBBB

Where it's running

• Azienda Ospedaliero-Universitaria Pisana
  Pisa, Pi, Italy Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ultrasound vs CT calcium scoring to reclassify symptomatic chest pain

  This study tests whether carotid ultrasound can reclassify risk in adults with chest pain and suspected chronic coronary syndrome, compared with the CT calcium score.

  Recruiting London North West Healthcare NHS Trust · Harrow · NCT07696533

• AI-powered ECG diagnosis and prognosis for hypertrophic cardiomyopathy

  This project will test whether artificial intelligence reading standard 12-lead ECGs can identify different types of hypertrophic cardiomyopathy and tell them apart from look‑alike heart conditions in adults.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07263204

• US benchmarking of heart and liver stiffness using shear wave ultrasound

  This project will test whether a new ultrasound device can measure heart and liver stiffness using shear wave velocity in people aged 60 or older with preserved or mildly reduced ejection fraction and left ventricular hypertrophy, with or without transthyretin amyloid cardiomyopathy, and in control subjects.

  Recruiting at 3 sites eMyosound SAS · Boston, Massachusetts and 2 other locations · NCT07215715

• µQFR to check side‑branch narrowing after a single stent in bifurcation coronary arteries

  This study will test whether µQFR from a single angiographic view can correctly detect functionally important side‑branch narrowing after single‑stent treatment in adults with obstructive coronary artery disease involving bifurcations.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07116083

• Faster cardiac MRI using deep-learning image reconstruction to measure left ventricular ejection fraction

  This will test whether a faster cardiac MRI scan using deep-learning reconstruction can accurately measure ejection fraction in adults referred for left ventricular hypertrophy.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens · NCT07061821

• Using echocardiograms and patient data to diagnose cardiac diseases

  This study is testing if using advanced technology to analyze heart ultrasound images along with patient information can help doctors better diagnose heart diseases.

  Recruiting Hospices Civils de Lyon · Pierre-Bénite · NCT05942729

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.